Serum levels of total p-cresylsulphate are associated with angiographic coronary atherosclerosis severity in stable angina patients with early stage of renal failure

Atherosclerosis

Volumn 211, Issue 2, 2010, Pages 579-583

  Wang, Chao Ping ^a,b   Lu, Li Fen ^a   Yu, Teng Hung ^a   Hung, Wei Chin ^a   Chiu, Cheng An ^a   Chung, Fu Mei ^a   Yeh, Lee Ren ^b   Chen, Han Jung ^a   Lee, Yau Jiunn ^c   Houng, Jer Yiing ^b  

^a E DA HOSPITAL   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c Lee's Endocrinologic Clinic   (Taiwan)

Author keywords

Modified Gensini score; Stable angina; Total p cresylsulphate

Indexed keywords

4 CRESYLSULPHATE; PARA CRESOL; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ADULT; ANGIOCARDIOGRAPHY; ARTERY OCCLUSION; ARTICLE; ATHEROSCLEROSIS; BLOOD ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STABLE ANGINA PECTORIS;

AGED; ANGINA PECTORIS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CRESOLS; CROSS-SECTIONAL STUDIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RENAL INSUFFICIENCY;

EID: 77955263041     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.03.036     Document Type: Article

References (20)

1. Schiffrin E.L., Lipman M.L., Mann J.F.E. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007, 116:85-97.
2. Glorieux G., Cohen G., Jankowski J., et al. Platelet/leukocyte activation, inflammation, and uremia. Semin Dial 2009, 22:423-427.
3. Jourde-Chiche N., Dou L., Cerini C., et al. Protein-bound toxins-update 2009. Semin Dial 2009, 22:334-339.
4. Liabeuf S, Barreto DV, Barreto FC, et al., on behalf of the European Uraemic Toxin Work Group (EUTox). Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. Nephrol Dial Transpl 2009;13.
5. Meijers B., Bammens B., DeMoor B., et al. Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int 2008, 73:1174-1180.
6. Vanholder R., De Smet R., Waterloos M.A., et al. Mechanisms of uremic inhibition of phagocyte reactive species production: characterization of the role of p-cresol. Kidney Int 1995, 47:510-517.
7. Schepers E., Meert N., Glorieux G., et al. p-Cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrol Dial Transpl 2007, 22:592-596.
8. Martinez A.W., Recht N.S., Hostetter T.H., et al. Removal of p-cresol sulfate by hemodialysis. J Am Soc Nephrol 2005, 16:3430-3436.
9. Chung F.M., Tsai J.C.R., Chang D.M., et al. Peripheral total and differential leukocyte count in diabetic nephropathy: the relationship of plasma leptin to leukocytosis. Diabetes Care 2005, 28:1710-1717.
10. Lee C.T., Kuo C.C., Chen Y.M., et al. Factors associated with blood concentration of indoxyl sulphate and p-cresol in patients undergoing peritoneal dialysis. Peritoneal Dial Int 2010, [Epub ahead of print].
11. Chung F.M., Yang Y.H., Shieh T.Y., et al. Effect of alcohol consumption on estimated glomerular filtration rate and creatinine clearance rate. Nephrol Dial Transpl 2005, 20:1610-1616.
12. Gensini G.G. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983, 51:606.
13. Wang C.P., Hsu H.L., Hung W.C., et al. Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin Endocrinol 2009, 70:876-882.
14. de Loor H., Bammens B., Evenepoel P., et al. Gas chromatographic mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uraemic and normal serum. Clin Chem 2005, 51:1535-1538.
15. Pang K.S., Schwab A.J., Goresky C.A., et al. Transport, binding, and metabolism of sulfate conjugates in the liver. Chem Biol Interact 1994, 92:179-207.
16. Meijers B.K., Van Kerckhoven S., Verbeke K., et al. The uremic retention solute p-cresyl sulfate and markers of endothelial damage. Am J Kidney Dis 2009, 54:891-901.
17. Meijers B.K., Bammens B., Verbeke K., et al. A review of albumin binding in CKD. Am J Kidney Dis 2008, 51:839-850.
18. Vanholder R., Massy Z., Argiles A., et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transpl 2005, 20:1048-1056.
19. Aoyama I., Niwa T. An oral adsorbent ameliorates renal overload of indoxyl sulfate and progression of renal failure in diabetic rats. Am J Kidney Dis 2001, 37(1 Suppl. 2):S7-S12.
20. Aoyama I., Shimokata K., Niwa T. An oral adsorbent downregulates renal expression of genes that promote interstitial inflammation and fibrosis in diabetic rats. Nephron 2002, 92:635-651.